http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View More Recent Stories
-
Avantor® and Catalent Enter into Multi-Year Supply and Services Agreement
-
Avantor® to Report Fourth Quarter and Full Year 2022 Earnings and Host Earnings Call on Friday, February 3, 2023
-
Avantor® to Participate in the 41st Annual J.P. Morgan Healthcare Conference
-
Avantor® to Participate in the 5th Annual Evercore ISI HealthCONx Conference
-
Avantor® Continues Investment to Support Biopharma Market with Opening of New Distribution Center in Dublin, Ireland
-
Avantor® to Host Third Quarter 2022 Earnings Call on Friday, October 28, 2022
-
Avantor and Avantor Foundation Make a Difference by Providing Critical Health Services for Vulnerable Communities in Singapore
-
Avantor® Names Kitty Sahin Executive Vice President, Strategy and Corporate Development
-
Avantor® to Host Second Quarter 2022 Earnings Call on Friday, July 29, 2022
-
Avantor Named Best Company for Upstream Processing and Single-Use Solutions at BMK 2022
-
Avantor (AVTR) Collaborates with GeminiBio to Bring Custom Hydrated Solutions and Cell Culture Media to Biopharma Customers
-
Avantor® to Collaborate with GeminiBio to Bring Custom Hydrated Solutions and Cell Culture Media to Biopharma Customers
-
Avantor® Releases 2022 Sustainability Report, Highlighting Significant Progress in Environmental, Social and Governance (ESG) Efforts
-
Jonathan Peacock Elected Chairman of the Board of Directors of Avantor®
-
Avantor® and Cytovance Biologics Collaborate to Accelerate Plasmid DNA Development for Biopharma Customers
-
Avantor (AVTR) Invests in Manufacturing and Distribution Hub in Singapore
-
Avantor® Announces Investment in Manufacturing and Distribution Hub in Singapore to Serve Rapidly Growing Asia Pacific Biopharma Industry
-
Avantor Announces Investment in Manufacturing and Distribution Hub in Singapore to Serve Rapidly Growing Asia Pacific Biopharma Industry
-
Pre-Open Stock Movers 04/04: (RCAT) (TWTR) (GGPI) Higher; (DWAC) (OCGN) (SBUX) Lower (more...)
-
Avantor Foundation Giving Surpasses $6 Million Since Inception
-
Avantor (AVTR) Announces Planned Retirement of Board Chair
-
Avantor® Announces Planned Retirement of Rajiv Gupta, Board Chairman
-
Avantor® Breaks Ground on New Distribution Center to Serve Growing Biopharmaceutical Industry in Ireland
-
Avantor® Opens Single-Use Logistics Hub to Strengthen Global Biopharma Supply Chain
-
Avantor Provides Critical Personal Protection Supplies to Vulnerable Populations through NGOs
-
Avantor® Opens Second European Single-use Facility in the Netherlands; Supports Growing Demand for Bioproduction
-
Avantor® Announces Investment in Hydration Capabilities to Address Growing Demand for Biologics
-
Avantor® Publishes Inaugural Sustainability Report; Drives Positive Impact through Science for Goodness Platform
-
Avantor Named Best Company in Bioprocessing Excellence for Single-use Solutions and Best Bioprocessing Supplier for Upstream Processing at Biologics Manufacturing Korea 2021
-
Avantor® to Boost Global Production of Single-Use Technologies and Address Growing Biopharma Demand
-
Avantor Named Best Bioprocessing Supplier in Single-Use Manufacturing at Asia-Pacific Bioprocessing Excellence Awards 2021
-
Avantor® Sets Science in Motion for Goodness with Donations and Grants to Community-Based Organizations
-
Avantor® Opens New Biorepository Facility in Europe to Support Growing Demand for Scientific Research and Clinical Trial Sample Storage
-
Avantor® Discusses Cell & Gene Therapy Production Trends Through the Lens of COVID-19
-
Avantor® Discusses Supply Chain Readiness at 2020 World Vaccine Congress Europe
-
Avantor's General Counsel Justin Miller Honored as "Legend in Law" by The Burton Awards Program
-
Avantor® Appoints Frederic Vanderhaegen Executive Vice President, Americas and Europe
-
Avatar Holdings, Inc. (AVTR) Expands Life Sciences Innovation Center
-
Avantor® Expands Life Sciences Innovation Center to Address Bioprocessing Needs in Protein Science, Monoclonal Antibodies (mAbs), Cell and Gene Therapy
-
Avantor® Named to Fortune 500 List
-
Avantor® and the Avantor Foundation Provide Support to Address Coronavirus (COVID-19) Pandemic

